SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-016694
Filing Date
2024-05-14
Accepted
2024-05-14 17:00:59
Documents
63
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acrx20240331_10q.htm   iXBRL 10-Q 1267571
2 EXHIBIT 10.1 ex_666699.htm EX-10.1 346434
3 EXHIBIT 31.1 ex_666709.htm EX-31.1 7979
4 EXHIBIT 31.2 ex_666710.htm EX-31.2 7985
5 EXHIBIT 32.1 ex_666711.htm EX-32.1 5928
  Complete submission text file 0001437749-24-016694.txt   6218629

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tlph-20240331.xsd EX-101.SCH 52766
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlph-20240331_def.xml EX-101.DEF 368226
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlph-20240331_lab.xml EX-101.LAB 320024
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlph-20240331_pre.xml EX-101.PRE 391746
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tlph-20240331_cal.xml EX-101.CAL 34301
67 EXTRACTED XBRL INSTANCE DOCUMENT acrx20240331_10q_htm.xml XML 855808
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
TALPHERA, INC. (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 24945498
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)